PPARA and obesity due to melanocortin 4 receptor deficiency: Several compounds, such as peroxisome proliferators-activated receptor alpha (PPARα) agonist, can ameliorate insulin resistance and obesity and normalize hyperleptinemia and hyperinsulinemia independent of adipoinsular axis (Ye et al., 2001; Jeong and Yoon, 2009).